Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

230 Views

A1. Novel Agents

Poster Session: Novel Agents

(P-1088) Safety Study of Rifaquizinone in Dogs Following Intra-articular Administration

Friday, October 18, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Huan Wang, PhD (she/her/hers)

Director of pharmacology and toxicology
TenNor Therapeutics (Suzhou) Ltd
Suzhou, Jiangsu, China (People's Republic)

Co-Author(s)

QC

Qin Cheng, Master

TenNor Therapeutics (Suzhou) Ltd
Suzhou, Jiangsu, China
WK

Weijian Ke, Master

WuXi AppTec (Suzhou) CO., Ltd.
Suzhou, Jiangsu, China
Zhenkun Ma, PhD (he/him/his)

CEO
TenNor Therapeutics
Suzhou Industrial Park, Jiangsu, China (People's Republic)